Content in Context
lies beneath (28 KB PDF)
by Ann M. Thayer
and Noteworthy (232 KB PDF)
Stem cells have a heart SARS in the sights Microfluidics: Cheaper
and easier FDA: More with less? Lilly joins Sirna in RNAi
Nonprofit drug development Quantum dot toxicity? Nanofiber brain
Focus on Business
People and Perspectives
discovery doldrums (64 KB PDF)
by Randall C. Willis
NCEs are coming slowly; J┘rgen Drews explains why.
The Time Line
of Mannheim (80 KB PDF)
by Richard A. Pizzi
Roche took the lead role in diagnostics by absorbing an historic innovator.
Sites and Software
expression learned (76 KB PDF)
by David Filmore
˝Supervisedţ statistical techniques are gaining popularity for microarray analysis.
The Tool Box
cell-health monitoring (76 KB PDF)
by Lawrence Lem and Keith Olson
A baseline for cell-based screening assays
Rules and Regulators
and human tissues (108 KB PDF)
by Alan L. Jakimo and Karen Owen Dunlop
A framework for applying the new privacy regulations in drug R&D
Clinical Trials Track
apoptosis (68 KB PDF)
by Mark S. Lesney
Histone deacetylase inhibitors that trigger cell death are the subjects of several
cancer clinical trials.
For Your Health
by strand (72 KB PDF)
by Julie L. McDowell
Hair loss afflicts millions of men and women.
to Read (76 KB PDF)